Tag Archives: SNDX

Top Tech Stocks To Own For 2021

Shares of PERNOD RICARD S/ADR (OTCMKTS:PDRDY) have earned an average rating of “Hold” from the six analysts that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company.

A number of research analysts have recently commented on PDRDY shares. Zacks Investment Research lowered PERNOD RICARD S/ADR from a “buy” rating to a “hold” rating in a report on Thursday, April 5th. ValuEngine raised PERNOD RICARD S/ADR from a “hold” rating to a “buy” rating in a research note on Wednesday, April 4th. Finally, Goldman Sachs Group cut PERNOD RICARD S/ADR from a “buy” rating to a “neutral” rating in a research note on Sunday, March 18th.

Top Tech Stocks To Own For 2021: DCT Industrial Trust Inc(DCT)

DCT Industrial Trust Inc. operates as a publicly owned real estate investment trust. The firm provides its services to companies. Through its fund, it engages in the ownership, operation, and development of real estate properties. The firm specializes in the ownership, acquisition, development, and management of institutional capital management program. It invests in the real estate markets of United States and Mexico. The firm is also invests in selected international markets. It primarily invests in commercial real estate properties, including generic distribution warehouses and light industrial properties. The firm was formerly known as Dividend Capital Trust Inc. DCT Industrial Trust was founded in 2002 and is based in Denver, Colorado with additional offices in Atlanta, Georgia and Dallas, Texas.

Advisors’ Opinion:

  • [By Joseph Griffin]

    Shares of DCT Industrial Trust Inc (NYSE:DCT) have been given an average recommendation of “Hold” by the ten ratings firms that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $62.83.

  • [By Logan Wallace]

    DECENT (CURRENCY:DCT) traded down 20.5% against the U.S. dollar during the 1-day period ending at 23:00 PM ET on September 5th. Over the last seven days, DECENT has traded 14% lower against the U.S. dollar. DECENT has a total market cap of $8.35 million and approximately $216,900.00 worth of DECENT was traded on exchanges in the last day. One DECENT coin can now be purchased for $0.16 or 0.00002516 BTC on major exchanges including Bittrex, Upbit, BCEX and HitBTC.

Top Tech Stocks To Own For 2021: Banco De Chile(BCH)

Banco de Chile, together with its subsidiaries, provides personal and business baking products and services in Chile and the United States. Its personal banking product line comprises checking accounts, time deposits, money market accounts, demand deposits, now accounts, and prime now accounts. The company also offers lines of credit; credit card products, such as Travel Club, Global Pass, net.card, and PaySafe credit cards; and Internet banking services. Its business banking products and services include financial management products, such as checking accounts, foreign currency accounts, money market accounts, and prime now accounts, as well as a line of credit. In addition, the company provides business Visa, MasterCard, and Travel Club credit cards; and foreign trade services, as well as treasury banking services. Further, it offers various services, including securities brokerage, mutual fund management, factoring, insurance brokerage, financial advisory, and securitiz ation. As of December 31, 2009, the company operated a network of 246 retail branches and 154 Banco CrediChile branches, as well as a network of 1,588 automated teller machines and 415 self-consultation terminals. The company was founded in 1893 and is headquartered in Santiago, Chile.

Advisors’ Opinion:

  • [By Joseph Griffin]

    Shares of Banco de Chile (NYSE:BCH) have been given a consensus recommendation of “Sell” by the seven analysts that are currently covering the stock, MarketBeat.com reports. Five investment analysts have rated the stock with a sell recommendation and two have assigned a hold recommendation to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $91.00.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Banco de Chile (BCH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Bitcoin Cash (CURRENCY:BCH) traded 3.3% lower against the US dollar during the one day period ending at 23:00 PM E.T. on August 25th. One Bitcoin Cash coin can now be bought for about $520.83 or 0.07863301 BTC on popular exchanges including Mercatox, BTCC, Bit2C and xBTCe. Bitcoin Cash has a market capitalization of $9.02 billion and approximately $268.90 million worth of Bitcoin Cash was traded on exchanges in the last day. Over the last week, Bitcoin Cash has traded down 5.9% against the US dollar.

Top Tech Stocks To Own For 2021: Syndax Pharmaceuticals, Inc. (SNDX)

We are a clinical stage biopharmaceutical company developing entinostat as a combination therapy in multiple cancer indications with our initial focus on tumors that have shown sensitivity to immunotherapy, including lung cancer, melanoma, ovarian cancer and triple negative breast cancer, or TNBC. Entinostat is our oral, small molecule drug candidate that has direct effects on both cancer cells and immune regulatory cells, potentially enhancing the body’s immune response to tumors. The favorable safety profile of entinostat has been demonstrated in clinical trials in more than 900 cancer patients.   Advisors’ Opinion:

  • [By Logan Wallace]

    A number of brokerages have recently issued reports on SNDX. B. Riley began coverage on shares of Syndax Pharmaceuticals in a research report on Tuesday, January 8th. They issued a “buy” rating and a $40.00 price target on the stock. ValuEngine downgraded shares of Syndax Pharmaceuticals from a “hold” rating to a “sell” rating in a research report on Monday, February 4th. Finally, Zacks Investment Research downgraded shares of Syndax Pharmaceuticals from a “buy” rating to a “hold” rating in a research report on Wednesday, January 9th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $16.25.

    COPYRIGHT VIOLATION WARNING: “Syndax Pharmaceuticals (SNDX) Set to Announce Earnings on Thursday” was first published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another website, it was illegally copied and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be read at www.tickerreport.com/banking-finance/4188416/syndax-pharmaceuticals-sndx-set-to-announce-earnings-on-thursday.html.

    About Syndax Pharmaceuticals

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Syndax Pharmaceuticals (SNDX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Low Price Stocks To Buy For 2019

Either low-income Americans became rich this Black Friday, or Wal-Mart’s (NYSE:WMT) marketers do not know what they are doing.

For years, $133,653 Cartier watches and expensive jewelry were sold in upper scale stores, where high income Americans prefer to shop on Black Friday. 

This year, Cartier watches are being sold on the Walmart.com site.

But who will buy them? Will high income Americans trade the upscale store for Wal-Mart’s site? That sounds very unlikely to me. Shopping for luxury items is usually more about the experience of shopping rather than about price.

What about Wal-Mart’s low-income shoppers? That’s unlikely, too, as they cannot afford items that sell at a hefty multiple of their annual income. Besides, some of Wal-Mart’s shoppers do not even use credit cards, so how can they purchase $133,653 watches on-line?

For more than three decades, Wal-Mart ruled the US retailing industry. Its large stores and everyday low prices were too much for smaller neighborhood stores and supermarkets. Result? They went out of business shortly after Wal-Mart invaded their turf.

Top Low Price Stocks To Buy For 2019: Syndax Pharmaceuticals, Inc. (SNDX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) was down, falling around 21 percent to $8.76 after the company issued updated results from Phase 2 ENCORE trial of entinostat in combo with KEYTRUDA.

  • [By Logan Wallace]

    Several institutional investors have recently bought and sold shares of the company. BVF Inc. IL acquired a new position in shares of Syndax Pharmaceuticals during the 4th quarter worth about $28,326,000. Millennium Management LLC grew its position in shares of Syndax Pharmaceuticals by 18.9% during the 4th quarter. Millennium Management LLC now owns 516,500 shares of the company’s stock worth $4,525,000 after buying an additional 82,256 shares during the period. Geode Capital Management LLC grew its position in shares of Syndax Pharmaceuticals by 17.4% during the 4th quarter. Geode Capital Management LLC now owns 153,483 shares of the company’s stock worth $1,344,000 after buying an additional 22,803 shares during the period. Crestline Management LP grew its position in shares of Syndax Pharmaceuticals by 55.3% during the 4th quarter. Crestline Management LP now owns 83,139 shares of the company’s stock worth $728,000 after buying an additional 29,607 shares during the period. Finally, State Street Corp grew its position in shares of Syndax Pharmaceuticals by 32.8% during the 2nd quarter. State Street Corp now owns 81,327 shares of the company’s stock worth $1,137,000 after buying an additional 20,106 shares during the period. Institutional investors own 69.55% of the company’s stock.

    TRADEMARK VIOLATION WARNING: “Syndax Pharmaceuticals (SNDX) Rating Lowered to D at TheStreet” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at www.tickerreport.com/banking-finance/3364448/syndax-pharmaceuticals-sndx-rating-lowered-to-d-at-thestreet.html.

    About Syndax Pharmaceuticals

  • [By Jon C. Ogg]

    Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) was started with a Buy rating and assigned a $30 price target at H.C. Wainwright on July 12. This is a small $175 million market cap company at the time of the call, but the price target in this call was about 300% higher than the $7.10 closing price. Syndax has a 52-week range of $6.61 to $15.20, and its most recent closing price was $7.49. The cancer pipeline has been the focus for such large upside here, and at one point one analyst was pointing to Syndax rallying to as high as $40.

  • [By Logan Wallace]

    A number of brokerages have recently issued reports on SNDX. B. Riley began coverage on shares of Syndax Pharmaceuticals in a research report on Tuesday, January 8th. They issued a “buy” rating and a $40.00 price target on the stock. ValuEngine downgraded shares of Syndax Pharmaceuticals from a “hold” rating to a “sell” rating in a research report on Monday, February 4th. Finally, Zacks Investment Research downgraded shares of Syndax Pharmaceuticals from a “buy” rating to a “hold” rating in a research report on Wednesday, January 9th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $16.25.

    COPYRIGHT VIOLATION WARNING: “Syndax Pharmaceuticals (SNDX) Set to Announce Earnings on Thursday” was first published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another website, it was illegally copied and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be read at www.tickerreport.com/banking-finance/4188416/syndax-pharmaceuticals-sndx-set-to-announce-earnings-on-thursday.html.

    About Syndax Pharmaceuticals

Top Low Price Stocks To Buy For 2019: icad inc.(ICAD)

Advisors’ Opinion:

  • [By Max Byerly]

    iCAD (NASDAQ:ICAD) announced its earnings results on Tuesday. The technology company reported ($0.06) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.12) by $0.06, Bloomberg Earnings reports. iCAD had a negative net margin of 61.83% and a negative return on equity of 59.65%.

  • [By Lisa Levin]

     

    Losers
    Netshoes (Cayman) Limited (NASDAQ: NETS) shares dipped 43.73 percent to close at $2.87 on Tuesday as the company posted downbeat Q1 results.
    Cesca Therapeutics Inc. (NASDAQ: KOOL) shares dropped 29.01 percent to close at $0.80 after reporting Q1 results.
    SenesTech, Inc. (NASDAQ: SNES) shares fell 22.2 percent to close at $0.340 after reporting Q1 miss.
    Vipshop Holdings Limited (NYSE: VIPS) fell 19.95 percent to close at $12.08 after the company reported weaker-than-expected earnings for its first quarter on Monday.
    Image Sensing Systems, Inc. (NASDAQ: ISNS) fell 19.68 percent to close at $3.775 after reporting earnings were down year over year. First quarter earnings came in flat, down from 4 cents per share in the same quarter of last year. Sales came in at $3.01 million.
    Boxlight Corporation (NASDAQ: BOXL) dropped 18.47 percent to close at $9.62 on Tuesday after surging 77.44 percent on Monday.
    ENDRA Life Sciences Inc. (NASDAQ: NDRA) declined 16.21 percent to close at $2.43. ENDRA Life Sciences is expected to release quarterly earnings today.
    ALJ Regional Holdings, Inc. (NASDAQ: ALJJ) shares fell 16.13 percent to close at $1.79.
    Switch Inc (NYSE: SWCH) shares dropped 14.93 percent to close at $13.16 following a first-quarter earnings miss.
    Restoration Robotics Inc (NASDAQ: HAIR) fell 14.42 percent to close at $3.68 after reporting a first-quarter earnings miss.
    iCAD, Inc. (NASDAQ: ICAD) declined 13.01 percent to close at $3.41 following Q1 results.
    Intersections Inc. (NASDAQ: INTX) fell 12.44 percent to close at $1.97.
    Histogenics Corporation (NASDAQ: HSGX) declined 12.24 percent to close at $2.15.
    AZZ Inc. (NYSE: AZZ) fell 12.1 percent to close at $39.60 following Q3 earnings.
    Hallador Energy Company (NASDAQ: HNRG) fell 11.1 percent to close at $6.49.
    Integrated Media Technology Limited (NASDAQ: IMTE) dropped 10.66 percent to close at $16.93 on Tuesday.
    Myomo, Inc. (NYSE: MYO) slipp

Top Low Price Stocks To Buy For 2019: Heritage Financial Corporation(HFWA)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Heritage Financial (HFWA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    PCSB Bank (NASDAQ: PCSB) and Heritage Financial (NASDAQ:HFWA) are both small-cap finance companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings and institutional ownership.

  • [By Ethan Ryder]

    Greene County Bancorp (NASDAQ: GCBC) and Heritage Financial (NASDAQ:HFWA) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, dividends, valuation, earnings, profitability and analyst recommendations.

  • [By Stephan Byrd]

    Southern Missouri Bancorp (NASDAQ: SMBC) and Heritage Financial (NASDAQ:HFWA) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

  • [By Shane Hupp]

    UBS Group AG lifted its position in Heritage Financial Corp (NASDAQ:HFWA) by 351.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,457 shares of the financial services provider’s stock after purchasing an additional 18,256 shares during the period. UBS Group AG owned about 0.07% of Heritage Financial worth $717,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 5 Low Price Stocks To Watch For 2019

In some cases, something you don’t really want becomes a value if the price gets low enough. That explains some fast-food value menus, and it contributes to the appeal of dollar stores.

But there are other items — think Miami Marlins tickets or a bottle of Mountain Dew — that you don’t want no matter the price. Something you don’t want doesn’t become a deal because it’s cheap. It becomes a burden you’re stuck with, like an ugly painting you have to hang up every time the aunt who gave it to you visits.

In my view, Frontier Communications (NASDAQ:FTR) is all of those terrible things. Yes, it’s cheap, but that should not tempt investors. Buying a stock at a low price makes sense if there’s a reasonable expectation it will rise. Frontier seems like a deal compared with high-flying T-Mobile (NASDAQ:TMUS), but as I see it, that’s like saying a broken-down scooter is a good deal compared with a new Porsche.

T-Mobile CEO John Legere has led the company on an impressive run. Image source: Getty Images.

Top 5 Low Price Stocks To Watch For 2019: Syndax Pharmaceuticals, Inc. (SNDX)

Advisors’ Opinion:

  • [By ]

    Syndax (SNDX) is developing entinostat, a Class I HDAC inhibitor, for the treatment of solid tumors. Shares popped recently following the release of Syndax’s first quarter earnings results, but a bigger catalyst on the horizon is the upcoming ASCO oncology conference in June. Syndax is due to present updated data from the ENCORE-601 Phase 2 trial in melanoma and lung cancer.

  • [By Logan Wallace]

    Several institutional investors have recently bought and sold shares of the company. BVF Inc. IL acquired a new position in shares of Syndax Pharmaceuticals during the 4th quarter worth about $28,326,000. Millennium Management LLC grew its position in shares of Syndax Pharmaceuticals by 18.9% during the 4th quarter. Millennium Management LLC now owns 516,500 shares of the company’s stock worth $4,525,000 after buying an additional 82,256 shares during the period. Geode Capital Management LLC grew its position in shares of Syndax Pharmaceuticals by 17.4% during the 4th quarter. Geode Capital Management LLC now owns 153,483 shares of the company’s stock worth $1,344,000 after buying an additional 22,803 shares during the period. Crestline Management LP grew its position in shares of Syndax Pharmaceuticals by 55.3% during the 4th quarter. Crestline Management LP now owns 83,139 shares of the company’s stock worth $728,000 after buying an additional 29,607 shares during the period. Finally, State Street Corp grew its position in shares of Syndax Pharmaceuticals by 32.8% during the 2nd quarter. State Street Corp now owns 81,327 shares of the company’s stock worth $1,137,000 after buying an additional 20,106 shares during the period. Institutional investors own 69.55% of the company’s stock.

    TRADEMARK VIOLATION WARNING: “Syndax Pharmaceuticals (SNDX) Rating Lowered to D at TheStreet” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at www.tickerreport.com/banking-finance/3364448/syndax-pharmaceuticals-sndx-rating-lowered-to-d-at-thestreet.html.

    About Syndax Pharmaceuticals

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Syndax Pharmaceuticals (SNDX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Low Price Stocks To Watch For 2019: Intelsat S.A.(I)

Advisors’ Opinion:

  • [By Keith Noonan]

    Intelsat (NYSE:I) stock rocketed up 391.4% through the first six months of the year, according to data provided by S&P Global Market Intelligence. That performance made it the biggest gainer of any stock listed on the New York Stock Exchange through the first half of 2018.

  • [By Rich Smith]

    Shares of communications satellite operator Intelsat (NYSE:I) jumped more than 12% early Tuesday — for the second day in a row — before closing the day up a still-respectable 10.9%. Once again, the catalyst for the move appears to have been a simple press release.

  • [By Money Morning Staff Reports]

    That’s why today we’ll show you one of our expert recommendations along with the 10 top-performing penny stocks to watch this week…

    Penny Stocks Current Share Price
    (as of Feb. 20) Feb. 12-20 Gain
    (as of Feb. 20)
    POET Technologies Inc. (OTCMKTS: POETF) $0.4165 85.1%
    Finjan Holdings Inc. (Nasdaq: FNJN) $2.94 67.05%
    Intelsat SA (NYSE: I) $3.50 38.89%
    Genesis Healthcare Inc. (NYSE: GEN) $1.39 37.62%
    Paringa Resources Ltd. (OTCMKTS: PNGZF) $0.41 32.30%
    CytoDyn Inc. (OTCMKTS: CYDY) $0.76 31.03%
    Iconix Brand Group Inc. (Nasdaq: ICON) $1.65 30.95%
    AMERI Holdings Inc. (Nasdaq: AMRH) $2.49 29.69%
    Pangea Logistics Solutions Ltd. (Nasdaq: PANL) $2.87 26.99%
    MoSys Inc. (Nasdaq: MOSY) $1.47 25.68%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

  • [By Rich Smith]

    Another day, another 10%-plus move for Intelsat (NYSE:I) stock.

    It’s Thursday, and Intelsat is moving steadily higher in afternoon trading, tipping the scales up 16.1% as of 12:12 p.m. EDT. The question is “why?”

  • [By Ethan Ryder]

    Zacks Investment Research upgraded shares of IntelliPharmaCeutics Intl (NASDAQ:IPCI) (TSE:I) from a sell rating to a hold rating in a research note released on Tuesday.

Top 5 Low Price Stocks To Watch For 2019: Dean Foods Company(DF)

Advisors’ Opinion:

  • [By Steve Symington]

    But the rising tide didn’t lift all boats. Here’s why Applied Materials (NASDAQ:AMAT), Tesla (NASDAQ:TSLA), and Dean Foods (NYSE:DF) slumped today.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Dean Foods Company (NYSE: DF) is projected to report quarterly earnings at $0.11 per share on revenue of $1.85 billion.
    Discovery, Inc. (NASDAQ: DISCA) is expected to report quarterly earnings at $0.44 per share on revenue of $1.99 billion.
    Jacobs Engineering Group Inc. (NYSE: JEC) is estimated to report quarterly earnings at $0.89 per share on revenue of $3.63 billion.
    Henry Schein, Inc. (NASDAQ: HSIC) is expected to report quarterly earnings at $0.92 per share on revenue of $3.17 billion.
    Gartner, Inc. (NYSE: IT) is projected to report quarterly earnings at $0.57 per share on revenue of $926.18 million.
    The AES Corporation (NYSE: AES) is estimated to report quarterly earnings at $0.24 per share on revenue of $2.98 billion.
    Expeditors International of Washington, Inc. (NASDAQ: EXPD) is projected to report quarterly earnings at $0.64 per share on revenue of $1.71 billion.
    US Foods Holding Corp. (NYSE: USFD) is expected to report quarterly earnings at $0.32 per share on revenue of $5.98 billion.
    DISH Network Corporation (NASDAQ: DISH) is expected to report quarterly earnings at $0.7 per share on revenue of $3.50 billion.
    Zebra Technologies Corporation (NASDAQ: ZBRA) is estimated to report quarterly earnings at $2.06 per share on revenue of $936.98 million.
    Camping World Holdings, Inc. (NYSE: CWH) is expected to report quarterly earnings at $0.42 per share on revenue of $1.06 billion.
    Perrigo Company plc (NYSE: PRGO) is projected to report quarterly earnings at $1.14 per share on revenue of $1.21 billion.
    Petróleo Brasileiro S.A. – Petrobras (NYSE: PBR) is estimated to report quarterly earnings at $0.28 per share on revenue of $23.80 billion.
    JD.com, Inc. (NYSE: JD) is projected to report quarterly earnings at $0.18 per share on revenue of $15.65 billion.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) is projected to report quarterly earnings at $0.6 per share o
  • [By Shane Hupp]

    Edgestream Partners L.P. boosted its holdings in shares of Dean Foods Co (NYSE:DF) by 16.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 51,086 shares of the company’s stock after buying an additional 7,366 shares during the period. Edgestream Partners L.P. owned approximately 0.06% of Dean Foods worth $537,000 as of its most recent SEC filing.

  • [By Travis Hoium]

    Shares of food and milk supplier Dean Foods Co (NYSE:DF) jumped as much as 15.3% in trading Tuesday after reporting first-quarter earnings that showed a nice improvement in the business. At 11:30 a.m. EDT shares had stabilized at a 10.6% gain on the day.

Top 5 Low Price Stocks To Watch For 2019: CoreSite Realty Corporation(COR)

Advisors’ Opinion:

  • [By Shane Hupp]

    In related news, SVP Steven James Smith sold 3,200 shares of the stock in a transaction that occurred on Wednesday, December 12th. The shares were sold at an average price of $100.00, for a total transaction of $320,000.00. Following the completion of the transaction, the senior vice president now owns 44,736 shares of the company’s stock, valued at approximately $4,473,600. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.50% of the stock is owned by company insiders.

    COPYRIGHT VIOLATION WARNING: “CoreSite Realty (COR) Updates FY 2019 Earnings Guidance” was first published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US and international copyright and trademark laws. The original version of this piece of content can be read at www.tickerreport.com/banking-finance/4134172/coresite-realty-cor-updates-fy-2019-earnings-guidance.html.

    About CoreSite Realty

  • [By Jack Delaney]

    Take CoreSite Realty Corp. (NYSE: COR), for example. The stock price not only climbed 43.66% from 2017 to 2018, but it also pays its shareholders a dividend of $3.92 per share.

  • [By Shane Hupp]

    CORION (CURRENCY:COR) traded down 6.2% against the U.S. dollar during the 1 day period ending at 13:00 PM Eastern on June 1st. In the last seven days, CORION has traded up 0.5% against the U.S. dollar. One CORION token can currently be purchased for $0.12 or 0.00001572 BTC on major cryptocurrency exchanges. CORION has a market cap of $0.00 and $4,199.00 worth of CORION was traded on exchanges in the last day.

  • [By Shane Hupp]

    CORION (CURRENCY:COR) traded 1.2% higher against the U.S. dollar during the one day period ending at 14:00 PM E.T. on August 30th. One CORION token can now be purchased for $0.0764 or 0.00001111 BTC on popular cryptocurrency exchanges. Over the last week, CORION has traded up 16.3% against the U.S. dollar. CORION has a total market capitalization of $0.00 and $1,192.00 worth of CORION was traded on exchanges in the last day.

Top 5 Low Price Stocks To Watch For 2019: ClearBridge Energy MLP Total Return Fund Inc.(CTR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Charles Taylor (LON:CTR) had its price objective upped by Liberum Capital from GBX 330 ($4.48) to GBX 385 ($5.22) in a report issued on Friday. The brokerage presently has a “buy” rating on the stock. Liberum Capital’s target price would suggest a potential upside of 33.22% from the stock’s previous close.

  • [By Joseph Griffin]

    Charles Taylor (LON:CTR) had its price objective upped by Liberum Capital from GBX 330 ($4.48) to GBX 385 ($5.22) in a report issued on Friday. The brokerage presently has a “buy” rating on the stock. Liberum Capital’s target price would suggest a potential upside of 33.22% from the stock’s previous close.

  • [By Joseph Griffin]

    Charles Taylor (LON:CTR) had its price objective upped by Liberum Capital from GBX 330 ($4.48) to GBX 385 ($5.22) in a report issued on Friday. The brokerage presently has a “buy” rating on the stock. Liberum Capital’s target price would suggest a potential upside of 33.22% from the stock’s previous close.

Top 5 Performing Stocks To Watch Right Now

Whether you have an index fund, an actively managed portfolio or a tactical portfolio, for the past year or so, your portfolio probably has been doing so-so. Not performing poorly, but not doing great either. The portfolios of most investors arent crashing; they are sort of running in place.

See Also: 7 Good Stocks with Hidden Value

But we have witnessed huge rallies in recent weeks. And also huge declines. So whats going on?

To start with, the markets peaked about a year ago. Since then, investors have been on a volatile rollercoaster that has a downward bias.

The Dow Jones industrial average peaked at 18,351 a year ago and has had two major declines since then. Each recovery rally has not been able to surpass the peak.

Top 5 Performing Stocks To Watch Right Now: Intercept Pharmaceuticals, Inc.(ICPT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Intercept Pharmaceuticals (ICPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Sean Williams, Chuck Saletta, and Brian Feroldi]

    With this in mind, we picked the brains of three Motley Fool investors to gauge what biotech stock they believe investors should consider buying right now. Topping the list were mid-caps Intercept Pharmaceuticals (NASDAQ:ICPT) and Xencor (NASDAQ:XNCR), as well as biotech blue-chip Celgene (NASDAQ:CELG).

  • [By Sean Williams]

    As you can see, there’s a lot of excitement in the NASH space at the moment, and plenty of big drug stocks are itching to add a promising NASH drug to their product pipelines. But one name that continues to be left out in the cold is Intercept Pharmaceuticals (NASDAQ:ICPT).

Top 5 Performing Stocks To Watch Right Now: The Herzfeld Caribbean Basin Fund, Inc.(CUBA)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Media headlines about Herzfeld Caribbean Basin Fund, Inc. common stock (NASDAQ:CUBA) have been trending somewhat positive on Saturday, according to Accern Sentiment Analysis. The research firm rates the sentiment of news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Herzfeld Caribbean Basin Fund, Inc. common stock earned a news sentiment score of 0.00 on Accern’s scale. Accern also gave news stories about the investment management company an impact score of 48.5554072096128 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Top 5 Performing Stocks To Watch Right Now: Fiserv, Inc.(FISV)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Fiserv (NASDAQ:FISV)’s share price reached a new 52-week high and low during trading on Monday . The stock traded as low as $74.61 and last traded at $74.25, with a volume of 72911 shares changing hands. The stock had previously closed at $73.51.

  • [By Stephan Byrd]

    Envestnet Asset Management Inc. trimmed its stake in Fiserv (NASDAQ:FISV) by 22.2% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 40,589 shares of the business services provider’s stock after selling 11,568 shares during the period. Envestnet Asset Management Inc.’s holdings in Fiserv were worth $2,879,000 as of its most recent filing with the SEC.

  • [By Stephan Byrd]

    Fiserv (NASDAQ:FISV)’s share price hit a new 52-week high and low during trading on Thursday . The company traded as low as $76.14 and last traded at $74.93, with a volume of 49348 shares traded. The stock had previously closed at $75.96.

  • [By Logan Wallace]

    Fiserv (NASDAQ:FISV) was upgraded by stock analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a report released on Friday.

  • [By Max Byerly]

    Segall Bryant & Hamill LLC bought a new stake in Fiserv Inc (NASDAQ:FISV) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,586 shares of the business services provider’s stock, valued at approximately $256,000.

Top 5 Performing Stocks To Watch Right Now: iShares Intermediate Credit Bond (CIU)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of ARKANSAS FINANCIAL GROUP, INC.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=ARKANSAS+FINANCIAL+GROUP%2C+INC.

    These are the top 5 holdings of ARKANSAS FINANCIAL GROUP, INC.SPDR Dow Jones Industrial Average (DIA) – 239,571 shares, 25.69% of the total portfolio. Shares reduced by 2.73%iShares Core S&P Mid-Cap (IJH) – 277,760 shares, 23.14% of the total portfolio. Shares added by 0.52%iShares 1-3 Year Credit Bond ETF (CSJ) – 400,939 shares, 18.49% of the total portfolio. Shares added by 1.16%iShares Intermediate Credit Bond ETF (CIU) – 229,423 shares, 10.93% of the total portfolio. Shares reduced by 5.93%Vanguard Mid-Cap (VO) – 82,652 shares, 5.66% of the total p

  • [By WWW.GURUFOCUS.COM]

    For the details of Allianz Investment Management LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Allianz+Investment+Management+LLC

    These are the top 5 holdings of Allianz Investment Management LLCiShares iBoxx $ Investment Grade Corporate Bond (LQD) – 3,271,938 shares, 72.31% of the total portfolio. Shares added by 54.10%SPDR Portfolio Intermediate Term Corporate Bond (SPIB) – 2,000,000 shares, 12.63% of the total portfolio. New PositioniShares Intermediate Credit Bond ETF (CIU) – 618,046 shares, 12.48% of the total portfolio. Shares added by 757.25%Vanguard Short-Term Corporate Bond ETF (VCSH) – 88,000 shares, 1.3% of the total portfolio. Shares added by 35.38%iShares 1-3 Year Credit Bond ETF (CSJ) – 65,470 shares, 1.28% of the total portfolio. New Purchase: SPDR

Top 5 Performing Stocks To Watch Right Now: Syndax Pharmaceuticals, Inc. (SNDX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) was down, falling around 21 percent to $8.76 after the company issued updated results from Phase 2 ENCORE trial of entinostat in combo with KEYTRUDA.

  • [By ]

    Syndax (SNDX) is developing entinostat, a Class I HDAC inhibitor, for the treatment of solid tumors. Shares popped recently following the release of Syndax’s first quarter earnings results, but a bigger catalyst on the horizon is the upcoming ASCO oncology conference in June. Syndax is due to present updated data from the ENCORE-601 Phase 2 trial in melanoma and lung cancer.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Syndax Pharmaceuticals (SNDX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Safest Stocks To Invest In Right Now

Currencies, commodities, different stock sectors, and bonds…   For the last few days, they've been all over the place.   Investors and traders are digesting the news. They're trying to figure out what "President Trump" means for the world. They're trying to figure out where their money is safest… and where they'll make the biggest profits.   Today, we'll look at a few areas of the market that are likely to do well under Trump…  
I'll start with infrastructure. Trump plans to spend big to improve things like roads and bridges in the U.S. He has experience with construction. And he'll likely follow through on his promises here.   That bodes well for companies that produce building materials like stone, gravel, steel, and copper. Just look at the price action of companies like Martin Marietta Materials (MLM), Vulcan Materials (VMC), U.S. Steel (X), and Freeport-McMoRan (FCX) since the election. They've all shot higher.

Best Safest Stocks To Invest In Right Now: Kohl’s Corporation(KSS)

Advisors’ Opinion:

  • [By Chris Lange]

    On Thursday, look for Kohls Corp. (NYSE: KSS) to report its fiscal fourth-quarter results. The analysts consensus estimates are EPS of $1.75 and revenue of $6.74 billion. Shares were changing hands at $66.47 on Fridays close. The consensus price target is $65.35, and the stock has a 52-week range of $35.16 to $69.14.

  • [By Benzinga News Desk]

    Billionaire hedge funder Dan Loeb is seeing more opportunities to bet against the market this year: Link

    ECONOMIC DATA
    USA Import Price Index (MoM) for Apr 0.30% vs 0.50% Est; Prior 0.30%
    The University of Michigan's consumer sentiment index for May is schedule for release at 10:00 a.m. ET.
    The Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET.
    ANALYST RATINGS
    JPMorgan upgraded Verizon (NYSE: VZ) from Neutral to Overweight
    Stifel upgraded Kimbell Royalty Partners (NYSE: KRP) from Hold to Buy
    Credit Suisse downgraded Kohl's (NYSE: KSS) from Outperform to Neutral
    BTIG downgraded Symantec (NASDAQ: SYMC) from Buy to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

  • [By ]

    Macy’s (M) was downgraded by Morgan Stanley, which is hurting shares of Kohl’s (KSS) , according to TheStreet’s founder and Action Alerts PLUS Portfolio Manager Jim Cramer.

  • [By ]

    Cramer and the AAP team say their favorite part of the Kohl’s (KSS) story is its ties with Amazon (AMZN) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

Best Safest Stocks To Invest In Right Now: Lawson Products Inc.(LAWS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Lawson Products (NASDAQ:LAWS) is scheduled to announce its earnings results on Thursday, April 19th. Analysts expect the company to announce earnings of $0.16 per share for the quarter.

Best Safest Stocks To Invest In Right Now: Syndax Pharmaceuticals, Inc. (SNDX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Several institutional investors have recently bought and sold shares of the company. BVF Inc. IL acquired a new position in shares of Syndax Pharmaceuticals during the 4th quarter worth about $28,326,000. Millennium Management LLC grew its position in shares of Syndax Pharmaceuticals by 18.9% during the 4th quarter. Millennium Management LLC now owns 516,500 shares of the company’s stock worth $4,525,000 after buying an additional 82,256 shares during the period. Geode Capital Management LLC grew its position in shares of Syndax Pharmaceuticals by 17.4% during the 4th quarter. Geode Capital Management LLC now owns 153,483 shares of the company’s stock worth $1,344,000 after buying an additional 22,803 shares during the period. Crestline Management LP grew its position in shares of Syndax Pharmaceuticals by 55.3% during the 4th quarter. Crestline Management LP now owns 83,139 shares of the company’s stock worth $728,000 after buying an additional 29,607 shares during the period. Finally, State Street Corp grew its position in shares of Syndax Pharmaceuticals by 32.8% during the 2nd quarter. State Street Corp now owns 81,327 shares of the company’s stock worth $1,137,000 after buying an additional 20,106 shares during the period. Institutional investors own 69.55% of the company’s stock.

    TRADEMARK VIOLATION WARNING: “Syndax Pharmaceuticals (SNDX) Rating Lowered to D at TheStreet” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at www.tickerreport.com/banking-finance/3364448/syndax-pharmaceuticals-sndx-rating-lowered-to-d-at-thestreet.html.

    About Syndax Pharmaceuticals

  • [By ]

    Syndax (SNDX) is developing entinostat, a Class I HDAC inhibitor, for the treatment of solid tumors. Shares popped recently following the release of Syndax’s first quarter earnings results, but a bigger catalyst on the horizon is the upcoming ASCO oncology conference in June. Syndax is due to present updated data from the ENCORE-601 Phase 2 trial in melanoma and lung cancer.

  • [By Lisa Levin]

    Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) was down, falling around 21 percent to $8.76 after the company issued updated results from Phase 2 ENCORE trial of entinostat in combo with KEYTRUDA.

  • [By Lisa Levin]

    Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) was down, falling around 22 percent to $8.634 after the company issued updated results from Phase 2 ENCORE trial of entinostat in combo with KEYTRUDA.

Best Safest Stocks To Invest In Right Now: Intec Pharma Ltd.(NTEC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Intec Pharma (NASDAQ:NTEC) has been assigned a $15.00 target price by Oppenheimer in a research note issued to investors on Wednesday. The firm presently has a “buy” rating on the biotechnology company’s stock. Oppenheimer’s price objective would indicate a potential upside of 185.71% from the company’s current price.

Best Safest Stocks To Invest In Right Now: SuperValu Inc.(SVU)

Advisors’ Opinion:

  • [By Jeremy Bowman]

    Shares ofSUPERVALU Inc.(NYSE:SVU) were moving higher last month after the supermarket operator and supplier yielded to activist pressure and agreed to sell and lease back eight distribution centers in order to lower costs and improve its cash position. The stock surged on the news and finished the month up 15%, according to data from S&P Global Market Intelligence.

  • [By Lisa Levin] Companies Reporting Before The Bell
    United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
    The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
    Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
    Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
    Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
    The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
    Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
    3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
    JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
    Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
    Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
    Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
    Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
    The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
    Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
    PACCAR Inc (NASDAQ: PCAR) is projected to
  • [By Stephan Byrd]

    SuperValu (NYSE:SVU) – Northcoast Research issued their Q1 2019 earnings per share estimates for SuperValu in a note issued to investors on Wednesday, May 9th. Northcoast Research analyst C. Cerankosky expects that the company will earn $0.65 per share for the quarter. Northcoast Research also issued estimates for SuperValu’s Q2 2019 earnings at $0.55 EPS, Q3 2019 earnings at $0.30 EPS, Q4 2019 earnings at $0.54 EPS and FY2019 earnings at $2.04 EPS.

  • [By Lisa Levin] Gainers
    Daré Bioscience, Inc. (NASDAQ: DARE) shares jumped 56.69 percent to close at $1.27 on Wednesday on news that the company entered into worldwide license agreement for Juniper Pharmaceuticals' intravaginal ring technology platform.
    Vicor Corporation (NASDAQ: VICR) rose 26.84 percent to close at $37.10. Vicor posted Q1 earnings of $0.10 per share on sales of $65.2 million.
    AGM Group Holdings Inc. (NASDAQ: AGMH) climbed 25.56 percent to close at $10.61.
    Travelzoo (NASDAQ: TZOO) gained 24.7 percent to close at $9.75 following strong Q1 results.
    Intrepid Potash, Inc. (NYSE: IPI) shares climbed 19.24 percent to close at $4.71.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 18.73 percent to close at $18.64.
    Genprex, Inc. (NASDAQ: GNPX) climbed 18.28 percent to close at $5.89. Genprex expanded its operations to Cambridge, Mass.
    Scorpio Tankers Inc. (NYSE: STNG) rose 13.92 percent to close at $2.70 following Q1 results.
    Rocky Brands, Inc. (NASDAQ: RCKY) shares surged 13.57 percent to close at $23.85 after reporting Q1 results.
    Resonant Inc. (NASDAQ: RESN) shares rose 12.5 percent to close at $4.14 on Wednesday.
    USANA Health Sciences, Inc. (NYSE: USNA) jumped 11.24 percent to close at $106.85 following Q1 results.
    SUPERVALU Inc. (NYSE: SVU) rose 11.16 percent to close at $16.24 after the company reported Q4 results and agreed to sell and leaseback eight distribution centers for an aggregate purchase price of $483 million.
    K12 Inc. (NYSE: LRN) shares gained 10.74 percent to close at $15.36 following Q3 results.
    Tupperware Brands Corporation (NYSE: TUP) rose 9.15 percent to close at $46.28 as the company posted in-line quarterly earnings.
    Six Flags Entertainment Corporation (NYSE: SIX) shares climbed 8.49 percent to close at $64.18 as the company posted a narrower-than-expected loss for its first quarter.
    Carlisle Companies Incorporated (NYSE: CSL) gained 8.2 percent to close at $107.94 af

Best Safest Stocks To Invest In Right Now: 2U, Inc.(TWOU)

Advisors’ Opinion:

  • [By Brian Withers]

    2U Inc.’s (NASDAQ:TWOU) stock has had an amazing run since the company went public, up over 500% since the March 2014 IPO. The online education company posted stellar 2017 results and has continued robust revenue growth in Q1 2018 with 42% year-over-year growth. But the company still hasn’t posted a profit, with a net loss of $29.4 million in 2017, compared to a loss of $20.7 million in 2016. First-quarter results posted in early May showed a quarterly net loss of $14.9 million, and is the company projecting a full year net loss between $46.6 million and $44.7 million.

  • [By Todd Campbell]

    Investing in emerging growth stocks for the long haul can be a great way to produce market-beating returns, but with thousands of stocks to choose from, it can be tough figuring out which are worth owning. To help, I went searching for growth stocks that can be added to portfolios and pickedAtlassian Corp. (NASDAQ:TEAM), Mimecast (NASDAQ:MIME), and 2U Inc. (NASDAQ:TWOU) as my favorite stocks to buy in May. Read on to learn if these stocks are right for your portfolio, too.

  • [By Steve Symington]

    2U Inc.(NASDAQ:TWOU)announced first-quarter 2018 results on Thursday after the market closed, highlighting not only the strength of its core Graduate Program business, but also the growing influence of its short-course offerings following its acquisition of GetSmarter last year. Shares were up more than 6% on Friday as of this writing, so let’s settle in to learn more about what drove the online education-platform company this quarter, as well as what investors should be watching in the year ahead.